However, in many cancers, the expression of SSTR2 is reduced or lost, diminishing the antitumor effects of somatostatin.524,525 This reduction leads to decreased efficacy of somatostatin and its analogs in treatment. This evidence concerns the gene SSTR2 and cancer.